Skip to content
2000
image of A Rare Case of Peripheral Edema Induced by Topical Minoxidil: 
A Case Report

Abstract

Introduction

Minoxidil, initially developed as an oral antihypertensive, is widely used topically for hair regrowth. Off-label applications, such as beard enhancement, have gained popularity. While generally safe, systemic absorption of topical minoxidil can lead to rare side effects, like peripheral edema.

Case Presentation

A 17-year-old male developed peripheral edema seven weeks after starting topical minoxidil 5% to promote beard growth. Initially, he experienced mild headaches in the fifth week, which resolved spontaneously. By the seventh week, he noticed swelling, which was exacerbated by prolonged immobility. Diagnostic evaluations, including Doppler ultrasound, echocardiography, ECG, and blood tests, were unremarkable. Edema resolved completely one to two weeks after discontinuation of minoxidil.

Conclusion

Minoxidil’s vasodilatory mechanism, which supports hair growth, can also lead to systemic effects, like peripheral edema due to fluid retention and increased capillary hydrostatic pressure. While rare with topical formulations, systemic absorption is influenced by factors, such as application area, concentration, and individual skin permeability. This case highlights a rare but clinically significant systemic side effect of topical minoxidil.

Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863383206250417083121
2025-05-06
2025-08-18
Loading full text...

Full text loading...

References

  1. Rossi A. Cantisani C. Melis L. Iorio A. Scali E. Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat. Inflamm. Allergy Drug Discov. 2012 6 2 130 136 10.2174/187221312800166859 22409453
    [Google Scholar]
  2. Patel P. Nessel T.A. Kumar D.D. Minoxidil. StatPearls Publishing Treasure Island, FL 2025
    [Google Scholar]
  3. Rulemaking history for OTC hair growth and loss drug products. 2017 Available from: https://www.fda.gov/drugs/historical-status-otc-rulemakings/rulemaking-history-otc-hair-growth-and-loss-drug-products
  4. Drug approval package. 2006 Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021812s000TOC.cfm
  5. Public assessment report: Minoxidil Xiromed 20 mg/ml and 50 mg/ml cutaneous solution. 2019 Available from: https://www.geneesmiddeleninformatiebank.nl/pars/h118101.pdf
  6. Minoxidil Teva 50 mg/ml, oplossing voor cutaan gebruik. 2024 Available from: https://db.cbg-meb.nl/ords/f?p=111:3:ATC:P0_DOMAIN,P0_LANG,P3_RVG1:H,NL,126372
  7. Almurayshid A. Review of topical therapies for beard enhancement. Indian J. Pharm. Sci. 2020 82 3 19 25 10.36468/pharmaceutical‑sciences.spl.139
    [Google Scholar]
  8. Vañó-Galván S. Pirmez R. Hermosa-Gelbard A. Moreno-Arrones Ó.M. Saceda-Corralo D. Rodrigues-Barata R. Jimenez-Cauhe J. Koh W.L. Poa J.E. Jerjen R. Trindade de Carvalho L. John J.M. Salas-Callo C.I. Vincenzi C. Yin L. Lo-Sicco K. Waskiel-Burnat A. Starace M. Zamorano J.L. Jaén-Olasolo P. Piraccini B.M. Rudnicka L. Shapiro J. Tosti A. Sinclair R. Bhoyrul B. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J. Am. Acad. Dermatol. 2021 84 6 1644 1651 10.1016/j.jaad.2021.02.054 33639244
    [Google Scholar]
  9. Ramelet A.A. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology 2001 52 Suppl 1 S49 S56 10.1177/0003319701052001S07 11510597
    [Google Scholar]
  10. Labrid C. Pharmacologic properties of Daflon 500 mg. Angiology 1994 45 6 Pt 2 524 530 8203782
    [Google Scholar]
  11. Gupta A.K. Talukder M. Venkataraman M. Bamimore M.A. Minoxidil: A comprehensive review. J. Dermatolog. Treat. 2022 33 4 1896 1906 10.1080/09546634.2021.1945527 34159872
    [Google Scholar]
  12. Messenger A.G. Rundegren J. Minoxidil: Mechanisms of action on hair growth. Br. J. Dermatol. 2004 150 2 186 194 10.1111/j.1365‑2133.2004.05785.x 14996087
    [Google Scholar]
  13. Largeau B. Cracowski J.L. Lengellé C. Sautenet B. Jonville-Béra A.P. Drug‐induced peripheral oedema: An aetiology‐based review. Br. J. Clin. Pharmacol. 2021 87 8 3043 3055 10.1111/bcp.14752 33506982
    [Google Scholar]
  14. Kikuchi S. Fujita Y. Onodera M. Fujino Y. Inoue Y. Prolonged hypotension induced by ingesting a topical minoxidil solution: Analysis of minoxidil and its metabolites. Acute Med. Surg. 2016 3 4 384 387 10.1002/ams2.196 29123818
    [Google Scholar]
  15. Sica D.A. Minoxidil: An underused vasodilator for resistant or severe hypertension. J. Clin. Hypertens. 2004 6 5 283 287 10.1111/j.1524‑6175.2004.03585.x 15133413
    [Google Scholar]
  16. U.S. Food and Drug Administration Pharmacology review: NDA 21-812 5% Minoxidil. 2006 Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021812s000_PharmR.pdf
  17. Franz T.J. Percutaneous absorption of minoxidil in man. Arch. Dermatol. 1985 121 2 203 206 10.1001/archderm.1985.01660020061018 3977334
    [Google Scholar]
  18. Georgala S. Befon A. Maniatopoulou E. Georgala C. Topical use of minoxidil in children and systemic side effects. Dermatology 2007 214 1 101 102 10.1159/000096924 17191059
    [Google Scholar]
  19. Naranjo C.A. Busto U. Sellers E.M. Sandor P. Ruiz I. Roberts E.A. Janecek E. Domecq C. Greenblatt D.J. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 1981 30 2 239 245 10.1038/clpt.1981.154 7249508
    [Google Scholar]
  20. Dolezal L. Lyons B. Health-related shame: An affective determinant of health? Med. Humanit. 2017 43 4 257 263 10.1136/medhum‑2017‑011186 28596218
    [Google Scholar]
/content/journals/cds/10.2174/0115748863383206250417083121
Loading
/content/journals/cds/10.2174/0115748863383206250417083121
Loading

Data & Media loading...


  • Article Type:
    Case Report
Keywords: Minoxidil ; side effects ; case report ; beard growth ; peripheral edema ; topical
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test